While most LEVs are rare, common risk variants with substantial effects are observed in Type 1 diabetes (i.e., the high-risk HLA-DR haplotype), breast cancer (i.e., BRCA1 and BRCA2 mutations)17, and Alzheimer’s Disease (i.e., APOE4 haplotype). This evidence concerns the gene BRCA1 and breast carcinoma.